MedPath

Nafcillin

Nafcillin for Injection, USP

Approved
Approval ID

a6a4e122-b7f5-4eb5-8555-7aea6eda794b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 27, 2025

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 080579617

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nafcillin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-198
Application NumberANDA090005
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 27, 2025
FDA Product Classification

INGREDIENTS (1)

nafcillin sodiumActive
Quantity: 10 g in 100 mL
Code: 49G3001BCK
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nafcillin - FDA Drug Approval Details